Clin2
NCT03215862Possibly a fitNot yet recruiting

Fluids given during ERCP to help prevent pancreas inflammation

Post-ERCP Acute Pancreatitis

Treatments studied

Part of Digestive system clinical trials.

This study tests whether giving lactated Ringer’s solution (a specific IV fluid) during an ERCP procedure can lower the chance of developing post-ERCP pancreatitis (painful pancreas inflammation after the procedure). You may be considered if your ERCP has a higher risk of triggering pancreatitis.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
242 people
Ages
18 years to 74 years
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You can understand the study and sign consent
  • You are not pregnant and will not be pregnant during the study
  • You are scheduled for a planned ERCP-related intervention that is considered high-risk
  • You do NOT have active acute pancreatitis or ongoing/chronic pancreatitis
  • You can safely receive extra IV fluids (no major fluid overload, severe kidney disease, low/high sodium, or serious heart/lung problems)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06260878Recruiting· Phase 4
Fluids before ERCP to prevent pancreatitis

This trial tests if giving fluids before an ERCP procedure can lower the risk of developing pancreatitis (inflammation of the pancreas). It may help people who have not had this procedure before.

Calgary, Alberta
NCT05252754Recruiting· Phase 3
Medicines to prevent pancreas swelling after ERCP

This Phase 3 study tests whether putting an anti-inflammatory medicine into the rectum (indomethacin) plus taking an immune-suppressing pill (tacrolimus) works better than using the two medicines in a different combination to prevent pancreatitis after an ERCP procedure. If you qualify, you may be assigned to one of the treatment options to lower your risk of post-ERCP pancreas inflammation.

Baltimore, Maryland
NCT07776561Recruiting
Short-stay IV fluids to prevent pancreatitis after ERCP

This trial tests whether giving extra IV fluids before, during, and after an ERCP procedure can help prevent a common complication called post-ERCP pancreatitis (inflammation of the pancreas). If you are scheduled for an ERCP, you may be eligible to participate.

Westmead, New South Wales
NCT05211206Recruiting
IV fluids to prevent pancreas inflammation after ERCP

This study tests whether giving IV (through-the-vein) fluids during/around an ERCP procedure can lower the risk of painful pancreas inflammation afterward. It may help patients by reducing a common complication after ERCP.

Calgary, Alberta
NCT05667987Recruiting
Lidocaine to help prevent pancreas inflammation after ERCP

This study tests whether giving lidocaine during an ERCP procedure can lower the risk of a painful complication called pancreatitis. If you’re scheduled for ERCP with a “never-treated” opening, this trial may see if lidocaine helps you avoid post-procedure pancreas inflammation.

Paris
NCT07756476Recruiting
Fluid treatment guided by heart response for acute pancreatitis

This study tests whether giving IV fluids based on how your heart responds can improve recovery from acute pancreatitis, compared with usual care. It may help your body handle fluids better during treatment.

Los Angeles, California

Hear when a new Post-ERCP Acute Pancreatitis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.